TOFACITINIB IN THE MANAGEMENT OF ULCERATIVE COLITIS REFRACTORY TO ANTI-TNF AND ANTI-INTEGRIN THERAPIES

Overview of attention for article published in Arquivos de Gastroenterologia, June 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 68 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 10,511 followers.

RT @fabioteixeira22: Ulcerative colitis refractory to anti-TNF and vesolizumab treated with success with tofacitinib; first case published…

28 Jul 2018

Reply Repost Favourite

RT @fabioteixeira22: Ulcerative colitis refractory to anti-TNF and vesolizumab treated with success with tofacitinib; first case published…

28 Jul 2018

Reply Repost Favourite

@pfizer @Y_ECCO_IBD @fbg @gediib_oficial @acg

27 Jul 2018

Reply Repost Favourite

Ulcerative colitis refractory to anti-TNF and vesolizumab treated with success with tofacitinib; first case published in South America https://t.co/6zvPmLnOtm

27 Jul 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.